ArticleNPJ precision oncology2026

AI-driven multi-omics drug repurposing nominates AZD7762 as a multitarget inhibitor of IL22RA1 and FAM221A in esophageal squamous cell carcinoma.

Zhan Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.